ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus.

Wang C, Liu X, Fu X, Yu X, Li M, Guan X.

Open source

DOI
10.1007/s10238-026-02275-4
Published
2026-08-10
Container
Clin Exp Med
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10238-026-02275-4,
  title = {ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus.},
  author = {Wang C and  Liu X and  Fu X and  Yu X and  Li M and  Guan X.},
  year = {2026},
  journal = {Clin Exp Med},
  doi = {10.1007/s10238-026-02275-4},
  url = {https://doi.org/10.1007/s10238-026-02275-4}
}

RIS

TY  - JOUR
TI  - ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus.
AU  - Wang C
AU  -  Liu X
AU  -  Fu X
AU  -  Yu X
AU  -  Li M
AU  -  Guan X.
PY  - 2026
JO  - Clin Exp Med
DO  - 10.1007/s10238-026-02275-4
UR  - https://doi.org/10.1007/s10238-026-02275-4
ER  - 

APA

C, W., X, L., X, F., X, Y., M, L., & X., G. (2026). ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus.. Clin Exp Med. https://doi.org/10.1007/s10238-026-02275-4

Source records